Retraction: A deep insight into CAR-T cell therapy in non-Hodgkin lymphoma: application, opportunities, and future directions
- 1Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
- 2Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- 3College of Medicine, University of Sulaimani, Sulaimaniyah, Iraq
- 4Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaimaniyah, Iraq
- 5Department of Pediatric Dentistry, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia
- 6Department of Economics and Industrial Engineering, St. Petersburg University of Management and Economics, St. Petersburg, Russia
- 7Department of Postgraduate and Doctoral Studies, Russian New University, Moscow, Russia
- 8Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand
- 9Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia
- 10Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt
- 11Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russia
- 12Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States
- 13Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- 14Taneja College of Pharmacy, University of South Florida, Tampa, FL, United States
- 15Department of Pharmaceutical Science, Faculty of Pharmacy, Airlangga University, Subaraya, Indonesia
- 16German Cancer Research Center, Toxicology and Chemotherapy Unit (G401), Heidelberg, Germany
Citation: Marofi F, Rahman HS, Achmad MH, Sergeevna KN, Suksatan W, Abdelbasset WK, Mikhailova MV, Shomali N, Yazdanifar M, Hassanzadeh A, Ahmadi M, Motavalli R, Pathak Y, Izadi S and Jarahian M (2021) A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions. Front. Immunol. 12:681984. doi: 10.3389/fimmu.2021.681984
Received: 17 March 2021; Accepted: 12 May 2021;
Published: 23 June 2021; Retracted: 04 September 2023.
Edited by:
Manel Juan, Hospital Clínic de Barcelona, SpainReviewed by:
Hongbin Wang, California Northstate University, United StatesNahum Puebla-Osorio, University of Texas MD Anderson Cancer Center, United States